References
- Perry CM, Markham A . Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs 1999;57:805–43.
- Ekmekçi AY, Tufan FD, Çagatay A . A case report of bone marrow suppression caused by piperacillin/tazobactam. Nobel Med 2008;3:28–30.
- Gerber L, Wing EJ . Life-threatening neutropenia secondary to piperacillin/tazobactam therapy. Clin Infect Dis 1995; 21:1047–8.
- Lin SY, Huang JC, Shen MC, Chuang SH, Lee MH, Chen HC . Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient. Hemodial Int 2012;S1:50–3.
- Perez-Vazquez A, Pastor JM, Riancho JA . Immune thrombocytopenia caused by piperacillin/tazobactam. Clin Infect Dis 1998;27:650–1.
- Reichardt P, Handrick W, Linke A, Schille R, Kiess W . Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment—a retrospective analysis in 38 children with cystic fibrosis. Infection 1999;27:355–6.
- Ruiz-Irastorza G, Barreiro G, Aguirre C . Reversible bone marrow depression by high-dose piperacillin/tazobactam. Br J Haematol 1996;95:611–2.
- Uzun G, Onem Y, Hatipoglu M, Turhan V, Mutluoglu M, Ay H . Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection. Scand J Infect Dis 2013;45:73–6.
- Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, et al. Systematic review of piperacillin-induced neutropenia. Drug Saf 2007;30: 295–306.
- Peralta FG, Sánchez MB, Roíz MP, Pena MA, Tejero MA, Arjona R . Incidence of neutropenia during treatment of bone-related infections with piperacillin/tazobactam. Clin Infect Dis 2003;37:1568–72.
- Neftel KA, Hauser SP, Müller MR . Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J Infect Dis 1985;152:90–8.
- Singh N, Yu VL, Mieles LA, Wagener MM . Beta-lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Am J Med 1993;94:251–6.